C-Reactive Protein Testing Market: By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others), By End-use (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others) and Geography  

C-Reactive Protein Testing Market is expected to be valued at USD 2,892.2 million in 2022 and is poised to grow at a significant CAGR of 2.7% over 2023-2029. C-reactive protein testing (CRP), an acute-phase protein produced by the liver, increases in concentration in the blood due to an inflammatory disorder. The CRP test detects the amount of CRP in blood cells. This test identifies various types of infections such as Cardiovascular diseases, Arthritis, Cancer, etc. The increase in the geriatric population globally and the growing prevalence of infectious and chronic diseases such as cancer, diabetes, cardiovascular, and arthritis are some of the primary factors that can propel the growth of the CPR market.

Moreover, lower immunity and shifting toward an inactive lifestyle raise the demand for healthcare services which helps in the growth of the CPR market. Additionally, various initiatives are taken by the government, prominent market players, and non-profit organizations to increase awareness of CPR testing which can further boost the market growth. Furthermore, the presence of numerous rapid kits and point-of-care devices has promoted the growth of the CPR market. However, a wide variety of alternative disease testing approaches which is more accurate such as an echocardiogram (ultrasound), and electrocardiogram (ECG) for cardiac disease screening can hinder the market CPR growth. CPR testing has the ability to differentiate between pathological and physiological CPR levels which can treat inflammatory illnesses has created lucrative opportunities for new players to enter the market. Nevertheless, increasing healthcare demands and improved healthcare infrastructures have created an attractive opportunity to expand the market size. The key trend in the CPR market is the initiatives taken by the government to encourage the usage of point-of-care testing in healthcare centers which can further support to boost the CPR market.

C-Reactive Protein Testing Market Key Developments:

In January 2021, DM Vasudevan Agappe Diagnostic Limited, India verified the usage of the latex-supplemented immunoturbidimetric assay for a highly sensitive and extensive variety of C-reactive protein detection in human serum.
In July 2022, Bloom Diagnostics launched an inflammation test kit to detect and measure the presence of CPR.